ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 269 filers reported holding ARGENX SE in Q1 2023. The put-call ratio across all filers is 1.05 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $787 | -15.3% | 1,602 | -35.8% | 0.08% | -21.2% |
| Q1 2023 | $929 | -99.9% | 2,494 | -18.9% | 0.10% | 0.0% |
| Q3 2022 | $1,086,000 | +391.4% | 3,076 | +339.4% | 0.10% | +518.8% |
| Q1 2022 | $221,000 | -57.5% | 700 | -62.9% | 0.02% | -56.8% |
| Q1 2021 | $520,000 | +75.1% | 1,888 | +43.1% | 0.04% | +8.8% |
| Q2 2020 | $297,000 | +36.9% | 1,319 | -24.1% | 0.03% | +183.3% |
| Q1 2019 | $217,000 | -49.7% | 1,738 | -67.6% | 0.01% | -47.8% |
| Q1 2018 | $431,000 | – | 5,357 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |